arrow
S

Simon Kreutzfeldt

german cancer research center
H指数:20
被引数:2,341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms

晚期神经内分泌肿瘤的临床可操作基因组学和转录组学景观

Med
IF11.8
2026-04-300
OAAI
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor

多层分子分析为硬化性小圆细胞肿瘤的诊断和靶向治疗提供信息

2026-04-090
OA
The Knowledge Connector decision support system for multiomics-based precision oncology

基于多组学的精准肿瘤学知识连接器决策支持系统

2026-01-190
OAAI
Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data

基于真实世界患者数据的LLM驱动型CDSS在精准肿瘤学中负责AI的协作框架

2025-12-040
OAAI
Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy

高突变负荷及错配修复异常的转移性胰腺神经内分泌肿瘤在烷化剂化疗后的免疫治疗

2025-11-030
PRE
Germany’s national genomDE strategy

德国国家基因组策略

2025-10-150
PRE
CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial

CDK4/6抑制剂在晚期软骨肉瘤中的应用:NCT PMO-1601试验的最终结果

2025-07-070
OA
Multi-omic profiling in cholangiocarcinoma to enable scientific advancement within the DKFZ/NCT/DKTK MASTER study

多组学分析在胆管癌中的应用,以推动DKFZ/NCT/DKTK MASTER研究中的科学进展

2024-09-010
PRE
Inavolisib in cancers with activating PIK3CA mutations: Results from the CRAFT trial

Inavolisib在具有激活性PIK3CA突变的癌症中的研究:CRAFT试验的结果

2024-09-010
PRE
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology
2023-10-267
OAAI
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity
2023-10-013
OAAI
Value of broad molecular profiling for cancer diagnosis
2023-10-010
OA
Genomics-based personalized oncology of advanced thymic epithelial tumors
2023-04-040
PRE
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study

青少年和年轻成人患者肉瘤的综合分子谱分析: EORTC specta-aya国际概念验证研究的结果

2023-01-016
OA
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
2022-11-0128
OA